A controlled field trial of liver oral typhoid vaccine Ty21a
about
Control of Invasive Salmonella Disease in Africa: Is There a Role for Human Challenge Models?A review of typhoid fever transmission dynamic models and economic evaluations of vaccinationNew knowledge on pathogenesis of bacterial enteric infections as applied to vaccine developmentOverview of the impact of Typhoid and Paratyphoid fever. Utility of Ty21a vaccine (Vivotif®)Vaccine development in Staphylococcus aureus: taking the biofilm phenotype into consideration.Invasive non-typhoidal salmonella disease: an emerging and neglected tropical disease in Africa.Estimating the incidence of typhoid fever and other febrile illnesses in developing countries.Room temperature stabilization of oral, live attenuated Salmonella enterica serovar Typhi-vectored vaccines.A low gastric pH mouse model to evaluate live attenuated bacterial vaccines.Effect of a purA mutation on efficacy of Salmonella live-vaccine vectors.Use of Ensure® nutrition shakes as an alternative formulation method for live recombinant Attenuated Salmonella Typhi vaccines.Differential production of interleukin-12 mRNA by murine macrophages in response to viable or killed Salmonella spp.Oral immunization using live attenuated Salmonella spp. as carriers of foreign antigens.Evaluation of two Salmonella typhimurium hybrids as challenge organisms in a system for the assay of typhoid vaccines.Construction of a potential bivalent vaccine strain: introduction of Shigella sonnei form I antigen genes into the galE Salmonella typhi Ty21a typhoid vaccine strain.Building the case for wider use of typhoid vaccines.Effect of parenteral immunization on the intestinal immune response to Salmonella typhi Ty21a.Prior immunologic experience potentiates the subsequent antibody response when Salmonella strains are used as vaccine carriersA galE via (Vi antigen-negative) mutant of Salmonella typhi Ty2 retains virulence in humans.Oral immunization of mice with attenuated Salmonella enteritidis containing a recombinant plasmid which codes for production of the B subunit of heat-labile Escherichia coli enterotoxin.Construction of a potential live oral bivalent vaccine for typhoid fever and cholera-Escherichia coli-related diarrheas.Helicobacter pylori infection affects immune responses following vaccination of typhoid-naive U.S. adults with attenuated Salmonella typhi oral vaccine CVD 908-htrA.Meeting on establishment of consortium to study invasive Salmonelloses in Sub-Saharan Africa.Introduction of Shigella flexneri 2a type and group antigen genes into oral typhoid vaccine strain Salmonella typhi Ty21a.Some galE mutants of Salmonella choleraesuis retain virulence.Enteroadhesion fimbriae and enterotoxin of Escherichia coli: genetic transfer to a streptomycin-resistant mutant of the galE oral-route live-vaccine Salmonella typhi Ty21a.Oral vaccination of monkeys with an invasive Escherichia coli K-12 hybrid expressing Shigella flexneri 2a somatic antigen.Intestinal immunoglobulin A responses in rabbits to a Salmonella typhi strain harboring a Shigella sonnei plasmidVaccination of calves with a diaminopimelic acid mutant of Salmonella typhimurium.Case of Enteric Fever with Bicytopenia.Enteric infections due to Campylobacter, Yersinia, Salmonella, and Shigella. WHO Scientific Working Group[Intestinal Infections due to Campylobacter, Yersinia, Salmonella and Shigella]
P2860
Q26785760-0A706DB5-7A47-4D4B-B690-51E6D07ECFA5Q28088491-BB0B536D-A5A7-4048-9539-024FDFEC5001Q33628356-64131AFD-C824-4808-94A5-341BD982C068Q33690625-859CDD95-47C4-4A28-8F81-F32511BA7C13Q34113328-EF7BE770-108B-4A72-9C35-942F67413523Q34275116-EB5BEA49-15AE-42E4-AE80-84F7C7A2BD58Q34275918-D2144047-99C4-484E-947D-FB9075E51ACAQ34711665-7B825652-CEFB-4584-BE83-89A73783641FQ35086704-068F3A40-F5D9-4FB2-92EC-4557EDCC2E3DQ35097492-290B423F-F11A-4A2D-9C34-A5F4B7790321Q35338804-EC42A406-5C15-4BDB-99B9-AF8F626F9C78Q35479916-992BEB44-8F83-4A5F-B95D-899769B80D27Q35677333-18C1D48D-1FC6-4936-A84B-02487D699D29Q36335391-EC4294DA-9F0E-417A-8033-D3244CE18091Q36431701-1671BF48-B42A-4C89-9E41-84CF98604A90Q36824195-73F3D541-5267-48E6-8A2A-CB2AD02D9C30Q36957719-A8838C46-3E18-441D-82CE-23E2FDD0D134Q36988512-F75650A2-4CEF-4636-814B-2069EEBBC2D7Q37005140-F0789AEC-DB9B-4216-B40F-14346BBCA395Q37026113-92440BB8-15D0-49AE-987E-8695ABDE0F13Q37042161-CB1F86DB-87E7-4FA4-ACB9-52C465AEBB87Q37696600-91795762-3D84-42CE-9523-FE9ACA666E42Q38948666-1E199F5C-153D-4878-A562-E04C9ADEE52DQ40160672-AF09318C-2865-4F91-8723-8CF07DC1F078Q40161926-AECA9676-2AB3-4762-9E4B-34F369D9ABB1Q40166583-734C97CA-577A-40D8-9BD4-1B7D61883652Q40168452-8CB611E4-43C3-4259-BAC8-1BAFF511F4F4Q40598013-C63D3F07-EFEF-4EBC-9FA0-554133227435Q41870569-25C9DC3F-83D6-4B11-B85A-ACFCDA610C87Q49230203-D8961E6F-8098-4C7A-8C1B-C595416388E5Q57951583-B435EE08-742E-4953-9740-1895D9C3A856Q57951615-3160F0B9-815A-4000-A82A-F1B93175F4EB
P2860
A controlled field trial of liver oral typhoid vaccine Ty21a
description
1980 nî lūn-bûn
@nan
1980年の論文
@ja
1980年論文
@yue
1980年論文
@zh-hant
1980年論文
@zh-hk
1980年論文
@zh-mo
1980年論文
@zh-tw
1980年论文
@wuu
1980年论文
@zh
1980年论文
@zh-cn
name
A controlled field trial of liver oral typhoid vaccine Ty21a
@ast
A controlled field trial of liver oral typhoid vaccine Ty21a
@en
type
label
A controlled field trial of liver oral typhoid vaccine Ty21a
@ast
A controlled field trial of liver oral typhoid vaccine Ty21a
@en
prefLabel
A controlled field trial of liver oral typhoid vaccine Ty21a
@ast
A controlled field trial of liver oral typhoid vaccine Ty21a
@en
P2093
P2860
P1476
A controlled field trial of liver oral typhoid vaccine Ty21a
@en
P2093
Cerisier Y
Geoffroy P
Germanier R
el Tantawi AS
P2860
P304
P407
P577
1980-01-01T00:00:00Z